Join
Live feed
·
PRReleasevia Quantisnow
Sinovac Biotech, Ltd. logo

SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success' New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders

ByQuantisnow·Wall Street's wire, on your screen.
SVA· Sinovac Biotech, Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SVA (Sinovac Biotech, Ltd.) and more on Quantisnow.

SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success' New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders | Quantisnow